Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioma 2Glioblastoma 2Colorectal Neoplasms 2Neoplasms 1Digestive System Neoplasms 1Brain Neoplasms 1

Interventions

Irinotecan 35,10-methylenetetrahydrofolic acid 2tislelizumab 1spartalizumab 1repotrectinib 1pralsetinib 1palbociclib 1encorafenib 1Pemetrexed 1Levoleucovorin 1Leucovorin 1KRN-330 1Immune Checkpoint Inhibitors 1Imatinib Mesylate 1Gemcitabine 1Flucytosine 1Everolimus 1Cisplatin 1Cetuximab 1Capecitabine 1Ascorbic Acid 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Digestive System Neoplasms × Flucytosine × Clear all
NCT03724071 2023-06-23

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Transgene

Phase 1/2 Terminated
51 enrolled
Gastrointestinal

Digestive System Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡